Working... Menu

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant (CLEAR Serenity)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02988115
Recruitment Status : Completed
First Posted : December 9, 2016
Last Update Posted : September 25, 2018
Information provided by (Responsible Party):
Esperion Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 19, 2018
  Actual Study Completion Date : April 16, 2018
  Certification/Extension First Submitted : September 21, 2018